Literature DB >> 16675728

Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline.

Larry B Goldstein, Robert Adams, Mark J Alberts, Lawrence J Appel, Lawrence M Brass, Cheryl D Bushnell, Antonio Culebras, Thomas J Degraba, Philip B Gorelick, John R Guyton, Robert G Hart, George Howard, Margaret Kelly-Hayes, J V Ian Nixon, Ralph L Sacco.   

Abstract

BACKGROUND AND
PURPOSE: This guideline provides an overview of the evidence on various established and potential stroke risk factors and provides recommendations for the reduction of stroke risk.
METHODS: Writing group members were nominated by the committee chair on the basis of each writer's previous work in relevant topic areas and were approved by the American Heart Association Stroke Council's Scientific Statement Oversight Committee. The writers used systematic literature reviews (covering the time period since the last review published in 2001 up to January 2005), reference to previously published guidelines, personal files, and expert opinion to summarize existing evidence, indicate gaps in current knowledge, and when appropriate, formulate recommendations based on standard American Heart Association criteria. All members of the writing group had numerous opportunities to comment in writing on the recommendations and approved the final version of this document. The guideline underwent extensive peer review before consideration and approval by the AHA Science Advisory and Coordinating Committee.
RESULTS: Schemes for assessing a person's risk of a first stroke were evaluated. Risk factors or risk markers for a first stroke were classified according to their potential for modification (nonmodifiable, modifiable, or potentially modifiable) and strength of evidence (well documented or less well documented). Nonmodifiable risk factors include age, sex, low birth weight, race/ethnicity, and genetic factors. Well-documented and modifiable risk factors include hypertension, exposure to cigarette smoke, diabetes, atrial fibrillation and certain other cardiac conditions, dyslipidemia, carotid artery stenosis, sickle cell disease, postmenopausal hormone therapy, poor diet, physical inactivity, and obesity and body fat distribution. Less well-documented or potentially modifiable risk factors include the metabolic syndrome, alcohol abuse, drug abuse, oral contraceptive use, sleep-disordered breathing, migraine headache, hyperhomocysteinemia, elevated lipoprotein(a), elevated lipoprotein-associated phospholipase, hypercoagulability, inflammation, and infection. Data on the use of aspirin for primary stroke prevention are reviewed.
CONCLUSIONS: Extensive evidence is available identifying a variety of specific factors that increase the risk of a first stroke and providing strategies for reducing that risk.

Entities:  

Mesh:

Year:  2006        PMID: 16675728     DOI: 10.1161/01.STR.0000223048.70103.F1

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  231 in total

1.  Inclusion of stroke as an outcome and risk equivalent in risk scores for primary and secondary prevention of vascular disease.

Authors:  Mandip S Dhamoon; Mitchell S V Elkind
Journal:  Circulation       Date:  2010-05-11       Impact factor: 29.690

2.  The Scandinavian Solutions for Wellness study - a two-arm observational study on the effectiveness of lifestyle intervention on subjective well-being and weight among persons with psychiatric disorders.

Authors:  Vibeke Porsdal; Catherine Beal; Ole Kristian Kleivenes; Egil W Martinsen; Eva Lindström; Harriet Nilsson; Pär Svanborg
Journal:  BMC Psychiatry       Date:  2010-06-10       Impact factor: 3.630

3.  The triglyceride:high-density lipoprotein-cholesterol ratio and steno-occlusive disease in the intracranial arteries.

Authors:  Kyusik Kang; Kwangsub Lee; Sung-Hoon Chung
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

4.  Prevalence of hypertension by duration and age at exposure to the stroke belt.

Authors:  Virginia J Howard; Robert F Woolson; Brent M Egan; Joyce S Nicholas; Robert J Adams; George Howard; Daniel T Lackland
Journal:  J Am Soc Hypertens       Date:  2010 Jan-Feb

5.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

6.  Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic stroke.

Authors:  Azita Soltani; Wayne M Clark; Douglas R Hansmann
Journal:  Transl Stroke Res       Date:  2011-04-15       Impact factor: 6.829

7.  Fish consumption and risk of stroke and its subtypes: accumulative evidence from a meta-analysis of prospective cohort studies.

Authors:  P Xun; B Qin; Y Song; Y Nakamura; T Kurth; S Yaemsiri; L Djousse; K He
Journal:  Eur J Clin Nutr       Date:  2012-10-03       Impact factor: 4.016

Review 8.  Sex differences in stroke.

Authors:  Roy A M Haast; Deborah R Gustafson; Amanda J Kiliaan
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-03       Impact factor: 6.200

9.  Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.

Authors:  Margaret C Fang; Praveen Panguluri; Edward L Machtinger; Dean Schillinger
Journal:  Patient Educ Couns       Date:  2009-01-25

10.  Cerebral vasculopathy in a Chinese family with neurofibromatosis type I mutation.

Authors:  Jian-Tao Liang; Li-Rong Huo; Yu-Hai Bao; Zhen-Yu Wang; Feng Ling
Journal:  Neurosci Bull       Date:  2013-11-11       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.